- Home
- WKSP vs SCNX Comparison
WKSP vs SCNX Comparison
Compare WKSP & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WKSP | SCNX |
|---|---|---|
| Founded | 2003 | 2010 |
| Country | United States | United States |
| Employees | 81 | 9 |
| Industry | Auto Parts:O.E.M. | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2M | 15.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WKSP | SCNX |
|---|---|---|
| Price | $0.68 | $0.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $9.25 | $1.50 |
| AVG Volume (30 Days) | 340.5K | ★ 915.1K |
| Earning Date | 05-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $131.96 | $1,097.38 |
| Revenue Next Year | $24.81 | $239.80 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.57 | $0.24 |
| 52 Week High | $4.30 | $2.60 |
Technical Indicators
Market Signals| Indicator | WKSP | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 46.91 | 52.26 |
| Support Level | $0.59 | $0.37 |
| Resistance Level | $1.03 | $0.43 |
| Average True Range (ATR) | 0.07 | 0.03 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 47.17 | 47.02 |
Price Performance
Historical ComparisonAbout WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.